These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3047064)

  • 1. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli.
    Vermeulen C; Cross A; Byrne WR; Zollinger W
    Infect Immun; 1988 Oct; 56(10):2723-30. PubMed ID: 3047064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Weiss J; Victor M; Cross AS; Elsbach P
    Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
    Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.
    Allen PM; Roberts I; Boulnois GJ; Saunders JR; Hart CA
    Infect Immun; 1987 Nov; 55(11):2662-8. PubMed ID: 3312006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
    Bortolussi R; Ferrieri P; Björkstén B; Quie PG
    Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody 2-2-B kills K1-positive Escherichia coli in conjunction with cord blood neutrophils and sera, but not with spinal fluid.
    Cross AS; Wooldridge WH; Zollinger WD
    Pediatr Res; 1984 Aug; 18(8):770-2. PubMed ID: 6382138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.
    Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J
    J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK; Inzana TJ
    J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of capsular polysaccharide determines serum resistance in Escherichia coli K92.
    Suerbaum S; Friedrich S; Leying H; Opferkuch W
    Zentralbl Bakteriol; 1994 Aug; 281(2):146-57. PubMed ID: 7858342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections.
    Raff HV; Devereux D; Shuford W; Abbott-Brown D; Maloney G
    J Infect Dis; 1988 Jan; 157(1):118-26. PubMed ID: 3121759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
    Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
    Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
    Cross AS; Gemski P; Sadoff JC; Orskov F; Orskov I
    J Infect Dis; 1984 Feb; 149(2):184-93. PubMed ID: 6199436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.
    Schiff DE; Wass CA; Cryz SJ; Cross AS; Kim KS
    Infect Immun; 1993 Mar; 61(3):975-80. PubMed ID: 7679376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Host Recognition Mechanism of the K1 Capsule-Specific Phage of
    Gong Q; Wang X; Huang H; Sun Y; Qian X; Xue F; Ren J; Dai J; Tang F
    J Virol; 2021 Aug; 95(18):e0092021. PubMed ID: 34191582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.